Prevention of chemotherapy-induced febrile neutropenia (FN) by antibiotics (AB) versus antibiotics plus granulocyte-colony stimulating factor (G-CSF) in small cell lung cancer (SCLC): A randomized phase III study.

被引：0
|
作者：
Timmer-Bonte, J
Biesma, B
Smit, J
Wilschut, F
Akkermans, J
De Boo, T
Bootsma, G
Tjan-Heijnen, VC
机构：
[1] Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[2] Jeroen Bosch Hosp, Den Bosch, Netherlands
[3] Rijnstate Hosp, Arnhem, Netherlands
[4] Gelderse Vallei Hosp, Ede, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8002
引用
收藏
页码：729S / 729S
页数：1
相关论文
共 50 条
  • [41] DOcetaxel (DOC) plus RAmucirumab (RAM) with pegylated Granulocyte-colONy stimulating factor (PEG-G-CSF) for elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial (DRAGON study: WJOG9416L)
    Tokito, T.
    Hata, A.
    Hara, S.
    Tachihara, M.
    Okada, H.
    Tanaka, H.
    Sato, Y.
    Tabata, E.
    Watanabe, H.
    Takayama, Y.
    Toyozawa, R.
    Okamoto, I.
    Wakuda, K.
    Nakamura, A.
    Shimokawa, M.
    Yamamoto, N.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1023 - S1024
  • [42] A phase III, randomized multicenter study of induction with or without granulocyte colony stimulating factor (G-CSF) followed by intensive consolidation versus stem cell transplantation (PBSCT) in AML (preliminary results of Turkish Leukemia Study Group TLG95-002).
    Beksac, M
    Tunali, A
    Akoglu, T
    Dundar, S
    Paydas, S
    Ilhan, O
    Koc, H
    Ozcan, M
    Ovali, E
    Uysal, A
    Yalcin, A
    Akman, N
    Buyukkececi, F
    BLOOD, 1997, 90 (10) : 3805 - 3805
  • [43] Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: A prospective European organization for research and treatment of cancer-lung cancer group phase III trial-08923
    Ardizzoni, A
    Tjan-Heijnen, VCG
    Postmus, PE
    Buchholz, E
    Biesma, B
    Karnicka-Mlodkowska, H
    Dziadziuszko, R
    Burghouts, J
    van Meerbeeck, JP
    Gans, S
    Legrand, C
    Debruyne, C
    Giaccone, G
    Manegold, C
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) : 3947 - 3955
  • [44] Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer
    Scagliotti, GV
    Ricardi, U
    Crino, L
    Maranzano, E
    DeMarinis, F
    Morandi, MG
    Emiliani, E
    Rosti, G
    Figoli, F
    Bolzicco, G
    Masiero, P
    Gentile, A
    Tonato, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 (06) : 561 - 565
  • [45] Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive stage small-cell lung cancer: A multicenter randomized phase III study
    Pujol, JL
    Douillard, JY
    Riviere, A
    Quoix, E
    Lagrange, JL
    Berthaud, P
    BardonnetComte, M
    Polin, V
    Gautier, V
    Milleron, B
    Chomy, F
    Chomy, P
    Spaeth, D
    LeChevalier, T
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 2082 - 2089
  • [46] CONCOMITANT ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AND INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - 1ST RESULTS OF A MULTICENTER, OPEN-LABEL, PHASE-III STUDY IN RANDOMIZED PARALLEL GROUPS
    GEISSLER, K
    KOLLER, E
    HINTERBERGER, W
    NIEDERWIESER, D
    KNOBL, P
    PABINGER, I
    WERNER, D
    SCHERRER, R
    SCHWARZINGER, I
    FRIEDL, J
    JAEGER, U
    LECHNER, K
    BLOOD, 1994, 84 (10) : A231 - A231
  • [47] Randomized phase 3 study of a novel, long-acting G-CSF (SPI-2012) versus pegfilgrastim in the management of chemotherapy-induced neutropenia in early-stage breast cancer patients receiving docetaxel and cyclophosphamide (TC) (ADVANCE study)
    Schwartzberg, L.
    Vacirca, J. L.
    Hager, S. J.
    Adoo, C. S.
    Ibrahim, E. N.
    Bhat, G.
    Choi, M. R.
    Allen, L. F.
    Tedesco, K. L.
    Agajanian, R.
    CANCER RESEARCH, 2016, 76
  • [48] A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Zhou, Caicun
    Huang, Yunchao
    Wang, Donglin
    An, Changshan
    Zhou, Fuxiang
    Li, Yali
    Chen, Gongyan
    Wu, Changping
    He, Jianxing
    Wu, Gang
    Song, Xia
    Gao, Jianfei
    Liu, Wei
    Li, Baolan
    Shi, Jianhua
    Huang, Chen
    Yu, Jingrui
    Feng, Jueping
    Yue, Hongmei
    Shi, Meiqi
    Xia, Jielai
    CLINICAL LUNG CANCER, 2016, 17 (02) : 119 - 127
  • [49] Placebo-controlled, randomized, double-blind study on the efficacy of bone-marrow stem cell mobilization induced by granulocyte-colony stimulating factor (G-CSF) on improvement of ischemic heart failure undergoing delayed revascularization for ST segment elevation myocardial infarction (STEMI)
    Engelmann, MG
    Theiss, H
    Wintersperger, B
    Schönberg, S
    Franz, WM
    CIRCULATION, 2003, 108 (17) : 622 - 622
  • [50] CHEMORADIOTHERAPY WITH OR WITHOUT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF LIMITED-STAGE SMALL-CELL LUNG-CANCER - A PROSPECTIVE PHASE-III RANDOMIZED STUDY OF THE SOUTHWEST-ONCOLOGY-GROUP
    BUNN, PA
    CROWLEY, J
    KELLY, K
    HAZUKA, MB
    BEASLEY, K
    UPCHURCH, C
    LIVINGSTON, R
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1632 - 1641
12345